See more : Pareto Bank ASA (PARB.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Westlake Chemical Partners LP (WLKP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Westlake Chemical Partners LP, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- IPEVO Corporation (6858.TWO) Income Statement Analysis – Financial Results
- Patria Latin American Opportunity Acquisition Corp. (PLAO) Income Statement Analysis – Financial Results
- Mangal Credit and Fincorp Limited (MANCREDIT.BO) Income Statement Analysis – Financial Results
- The Kiley Group, Inc. (KGRI) Income Statement Analysis – Financial Results
- Euro Asia Exports Limited (EUROASIA.BO) Income Statement Analysis – Financial Results
Westlake Chemical Partners LP (WLKP)
About Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B | 1.29B | 1.17B | 986.74M | 1.01B | 1.75B | 2.13B | 2.25B | 2.25B |
| Cost of Revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M | 908.46M | 769.31M | 595.41M | 624.34M | 1.00B | 1.26B | 1.61B | 1.84B |
| Gross Profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M | 377.16M | 403.67M | 391.33M | 382.88M | 745.81M | 872.61M | 635.65M | 409.10M |
| Gross Profit Ratio | 32.54% | 23.69% | 36.36% | 39.19% | 34.75% | 29.34% | 34.41% | 39.66% | 38.01% | 42.63% | 41.01% | 28.26% | 18.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.09M | 26.62M | 28.58M | 22.16M | 26.95M | 24.62M | 27.26M | 21.97M | 20.68M | 21.30M | 24.05M | 22.49M | 0.00 |
| Selling & Marketing | 2.67M | 3.06M | 2.44M | 3.73M | 2.33M | 2.97M | 2.00M | 2.92M | 2.87M | 7.95M | 1.40M | 1.62M | 0.00 |
| SG&A | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Other Expenses | 0.00 | 1.57M | 62.00K | 733.00K | 3.10M | 2.46M | 1.79M | 601.00K | 160.00K | 3.15M | 7.70M | 4.19M | 2.80M |
| Operating Expenses | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Cost & Expenses | 833.08M | 1.25B | 804.17M | 613.68M | 741.72M | 936.05M | 798.57M | 620.29M | 647.89M | 1.03B | 1.28B | 1.64B | 1.87B |
| Interest Income | 0.00 | 13.41M | 8.82M | 12.04M | 19.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M | 21.43M | 21.86M | 12.61M | 4.97M | 10.50M | 8.03M | 8.94M | 8.95M |
| Depreciation & Amortization | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
| EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M | 460.87M | 490.18M | 464.92M | 440.51M | 797.32M | 928.32M | 679.99M | 444.78M |
| EBITDA Ratio | 39.65% | 29.52% | 42.77% | 47.26% | 42.18% | 35.85% | 41.79% | 47.15% | 43.75% | 45.57% | 43.63% | 30.23% | 19.76% |
| Operating Income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M | 349.57M | 374.41M | 366.44M | 359.33M | 716.56M | 847.16M | 611.55M | 384.79M |
| Operating Income Ratio | 30.04% | 21.82% | 33.81% | 36.52% | 32.07% | 27.19% | 31.92% | 37.14% | 35.68% | 40.95% | 39.81% | 27.19% | 17.09% |
| Total Other Income/Expenses | -22.27M | -11.84M | -8.75M | -11.31M | -16.53M | -18.98M | -20.07M | -12.01M | -4.81M | -7.35M | -331.00K | -4.75M | -6.14M |
| Income Before Tax | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M | 330.59M | 354.34M | 354.44M | 354.53M | 709.21M | 846.83M | 606.80M | 378.64M |
| Income Before Tax Ratio | 28.17% | 21.08% | 33.08% | 35.35% | 30.56% | 25.71% | 30.21% | 35.92% | 35.20% | 40.53% | 39.80% | 26.98% | 16.82% |
| Income Tax Expense | 813.00K | 1.02M | 549.00K | 564.00K | 728.00K | 22.00K | 1.28M | 1.04M | 672.00K | 199.39M | 300.28M | 210.88M | 131.67M |
| Net Income | 54.28M | 334.83M | 401.39M | 341.12M | 332.90M | 49.35M | 48.67M | 40.94M | 39.83M | 13.58M | 546.55M | 395.92M | 246.97M |
| Net Income Ratio | 4.56% | 21.02% | 33.04% | 35.29% | 30.49% | 3.84% | 4.15% | 4.15% | 3.95% | 0.78% | 25.69% | 17.60% | 10.97% |
| EPS | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.53 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| EPS Diluted | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.51 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| Weighted Avg Shares Out | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.24M | 28.39M | 27.06M | 27.06M | 27.06M | 25.37M | 25.37M | 25.37M |
| Weighted Avg Shares Out (Dil) | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.68M | 28.39M | 27.29M | 27.10M | 27.06M | 25.37M | 25.37M | 25.37M |
Westlake Chemical Partners LP Announces First Quarter 2023 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 35th quarterly distribution announced by the Partnership...
Westlake Chemical Partners LP Announces First Quarter 2023 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 35th quarterly distribution announced by the Partnership...
Westlake Chemical Partners Appoints Lisa Friel to Board of Directors
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed...
Westlake Chemical Partners Appoints Lisa Friel to Board of Directors
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed...
Westlake Chemical Partners Announce First Quarter 2023 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its first quarter 2023 earnings prior to the market opening on Thursday, May 4, 2023. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on...
Westlake Chemical Partners Announce First Quarter 2023 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its first quarter 2023 earnings prior to the market opening on Thursday, May 4, 2023. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on...
Woodside Energy Group Ltd Announces Changes to Woodside Board
Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside Board PERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of...
Westlake Chemical Partners LP Filed Annual Report
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 with the Securities and Exchange Commission on March 1, 2023. A copy of...
Westlake Chemical Partners LP Filed Annual Report
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 with the Securities and Exchange Commission on March 1, 2023. A copy of...
Are Investors Undervaluing Westlake Chemical Partners (WLKP) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Source: https://incomestatements.info
Category: Stock Reports